Journal of Molecular Endocrinology · 2011 · 49 citations · 41 references
Life SciencesOncologyPharmacologyCell SignalingMolecular OncologySignal TransductionHormonal Cancer TherapyHormonal TherapyHormone ReceptorsHormone SignalingSphingolipid MetabolismSteroid Hormone SignalingEstrogen Receptor ExpressionEstrogen Receptor SignalingPro-apoptotic EffectorsProgesterone Receptor ExpressionProgesterone Receptor SignalingSphingosine 1-Phosphate SignalingSphingosine-1-phosphate SignalingTherapeutic Target Identification
Recently, crosstalk between sphingolipid signaling pathways and steroid hormones has been illuminated as a possible therapeutic target. Sphingosine kinase (SK), the key enzyme metabolizing pro-apoptotic ceramide to pro-survival sphingosine-1-phosphate (S1P), is a promising therapeutic target for solid tumor cancers. In this study, we examined the ability of pharmacological inhibition of S1P formation to block estrogen signaling as a targeted breast cancer therapy. We found that the Sphk1/2 selective inhibitor (SK inhibitor (SKI))-II, blocked breast cancer viability, clonogenic survival and proliferation. Furthermore, SKI-II dose-dependently decreased estrogen-stimulated estrogen response element transcriptional activity and diminished mRNA levels of the estrogen receptor (ER)-regulated genes progesterone receptor and steroid derived factor-1. This inhibitor binds the ER directly in the antagonist ligand-binding domain. Taken together, our results suggest that SKIs have the ability to act as novel ER signaling inhibitors in breast carcinoma.
41
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
Olivier Cuvillier, Grisha Pirianov, Burkhard Kleuser et al. · Nature · 1996 · 1.5K citations
Julie M. Hall, Donald P. McDonnell · Endocrinology · 1999 · 1.1K citations · Full text
M. Berry, Daniel METZGER, Pierre Chambon · The EMBO Journal · 1990 · 772 citations · Full text
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Jeremy Brown, Bradly G. Wouters · PubMed · 1999 · 702 citations
Medicine, Cancer Biology, Oncology +17
Maty Tzukerman, A. Esty, Dolores Santiso‐Mere et al. · Molecular Endocrinology · 1994 · 648 citations · Full text